SSWM
SLXP

Sheets Smith Wealth Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Sheets Smith Wealth Management’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-10,380
Closed -$1.62M – 286
2014
Q3 		$1.62M Buy
10,380
+594
+6% +$86.1K 0.44% 69
2014
Q2 		$1.21M Buy
9,786
+2,123
+28% +$235K 0.32% 86
2014
Q1 		$794K Buy
7,663
+773
+11% +$79.1K 0.22% 123
2013
Q4 		$620K Buy
6,890
+3,727
+118% +$297K 0.17% 157
2013
Q3 		$212K Buy
+3,163
New +$218K 0.07% 225

Other funds holding SLXP

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sheets Smith Wealth Management's SLXP Position: Q4 2014 in Review

Sheets Smith Wealth Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q4 2014, closing a stake of 10,380 shares — an estimated $1.62M sold.

Sheets Smith Wealth Management first reported a position in SLXP in Q3 2013 and held it in 5 quarters. The position peaked at $1.62M in Q3 2014. 347 funds tracked by Wall St. Rank hold SLXP as of Q4 2014.

  • Sheets Smith Wealth Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q4 2014 after selling out during the quarter.
  • Sheets Smith Wealth Management sold 10,380 SALIX PHARMACEUTICALS LTD DEL shares in Q4 2014, an estimated $1.62M.
  • Sheets Smith Wealth Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2013 and held it in 5 quarters.
  • Sheets Smith Wealth Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.62M in Q3 2014.
  • 347 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q4 2014.

Based on Sheets Smith Wealth Management's 13F filing for Q4 2014, filed 20 Feb 2015.